Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-25

FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira's supplemental application for diazepam (generic) under ANDA 071583. This represents a supplemental approval for a generic diazepam product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)